Insider Trading & Ownership of John Johnson

Location: Seattle, WA
Summary: The estimated net worth of John Johnson is at least $8,068,722 dollars as of 08 May 2026. John Johnson is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $5.04M. John Johnson is the Executive Chairman, Director of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. stock worth about $2.92M. John Johnson is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116.5K.
Signature: /S/ Marc Began, as attorney-in-fact for John Johnson
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow John Johnson and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

John Johnson has 5 issuer positions tracked on this page.
Estimated disclosed ownership value: $8,068,722.
Recent insider filing activity is available below.

What Changed

Largest disclosed position: Xeris Biopharma Holdings, Inc. ($5,037,227).
Past-year value change for that position: -$1,763,479.

Why This Matters

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.